Kymab competitorsClear all

Kymab's top competitors include Histocell, Centurion, Intra-Cellular Therapies and Anchiano Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Kymab
Kymab
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
Histocell
Histocell
Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine.
Centurion
Centurion
Centurion is a biopharmaceutical company that focuses on manufacturing and launching biosimilar products.
Intra-Cellular Therapies
Intra-Cellular Therapies
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
Anchiano Therapeutics
Anchiano Therapeutics
Anchiano Therapeutics is a clinical-stage biotechnology company that develops gene therapies to treat early-stage bladder cancer.
Founding Date
Founding Date
2009
Founding Date
2011
Founding Date
1999
Founding Date
2002
Founding Date
2004
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Babraham, GB HQ
Locations
Derio, ES HQ
Larrabetzu, ES
Locations
TR HQ
Locations
New York, US HQ
Locations
Cambridge, US HQ
Employees
Employees
1681% decrease
Employees
22
Employees
981% increase
Employees
330352% increase
Employees
1912% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
3.5 b
Valuation ($)
34.9 m
Twitter followers
Twitter followers
1.1 k
Twitter followers
N/A
Twitter followers
138
Twitter followers
N/A
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
159371
Alexa Website Rank
332023
Alexa Website Rank
568771
Alexa Website Rank
359478
Alexa Website Rank
N/A
Employee Rating
Employee Rating
4.1
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.4
Employee Rating
N/A

Financial

Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($227m) (FY, 2020)
Net income
$9.8m (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 220.4m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 225.3m
Total funding raised
$ 29m
For sources of this data, please see the company profile

View company profiles

Histocell
HQ
Derio, ES
Employees
22

Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine.

View company
Centurion
HQ
TR
Employees
98↑ 1% increase

Centurion is a biopharmaceutical company that focuses on manufacturing and launching biosimilar products.

View company
Intra-Cellular Therapies
HQ
New York, US
Employees
330

Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.

View company
Anchiano Therapeutics
HQ
Cambridge, US
Employees
19↑ 12% increase

Anchiano Therapeutics is a clinical-stage biotechnology company that develops gene therapies to treat early-stage bladder cancer.

View company